The Intestinal Archaea Methanosphaera stadtmanae and Methanobrevibacter smithii Activate Human Dendritic Cells

Abstract

The methanoarchaea Methanosphaera stadtmanae and Methanobrevibacter smithii are known to be part of the indigenous human gut microbiota. Although the immunomodulatory effects of bacterial gut commensals have been studied extensively in the last decade, the impact of methanoarchaea in human's health and disease was rarely examined. Consequently, we studied and report here on the effects of M. stadtmanae and M. smithii on human immune cells. Whereas exposure to M. stadtmanae leads to substantial release of proinflammatory cytokines in monocyte-derived dendritic cells (moDCs), only weak activation was detected after incubation with M. smithii. Phagocytosis of M. stadtmanae by moDCs was demonstrated by confocal microscopy as well as transmission electronic microscopy (TEM) and shown to be crucial for cellular activation by using specific inhibitors. Both strains, albeit to different extents, initiate a maturation program in moDCs as revealed by up-regulation of the cell-surface receptors CD86 and CD197 suggesting additional activation of adaptive immune responses. Furthermore, M. stadtmanae and M. smithii were capable to alter the gene expression of antimicrobial peptides in moDCs to different extents.Taken together, our findings strongly argue that the archaeal gut inhabitants M. stadtmanae and M. smithii are specifically recognized by the human innate immune system. Moreover, both strains are capable of inducing an inflammatory cytokine response to different extents arguing that they might have diverse immunomodulatory functions. In conclusion, we propose that the impact of intestinal methanoarchaea on pathological conditions involving the gut microbiota has been underestimated until now.

Methanosphaera stadtmanae induces a type IV hypersensitivity response in a mouse model of airway inflammation

“…This raises the possibility that MSS is able to stimulate epithelial cells to produce IL-33. The mechanisms by which MSS could activate epithelial cells remain to be identified, as it was shown to be incapable of inducing an IL-8 release in human epithelial cell lines transformed with different TLRs and NLRs (Bang et al 2014).…”

The Role of Lung and Gut Microbiota in the Pathology of Asthma

“…Although understudied, archaea are consistently identified in human microbiota studies and their community composition differs according to body site (Koskinen et al, 2017). Methonoarchaea, including Methanobrevibacter smithii and Methanosphaera stadtmanae (M. stadtmanae), have been proposed as keystone members of this microbial community and possess immunogenic properties (Blais Lecours et al, 2011;Bang et al, 2014).…”

Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases

“…The potential inflammatory role of Euryarchaeota has previously been recognized. Considering their known ability to cause human dendritic cell activation (particularly Methanosphaera stadtmanae and Methanobrevibacter smithii [27]) and the increased abundance of M . stadtmanae often reported in IBD, further investigation is warranted.…”